Abstract
The elevated plus-maze (EPM) is a widely used animal model for screening of new pharmacological agents to anxiety as well as for studies on the neurobiology of defensive behaviors. Interestingly, the anxiolytic-like effect of benzodiazepines, such as midazolam, is abolished in rats or mice previously tested in the EPM, a phenomenon described as one-trial tolerance (OTT). Previous studies …